Japanese Data-Oriented New Drug Discovery Using Useful Bacteria

Abstract

Recently, the term of gut environment has been attracted in the relationship with health and diseases. In this background, the possibility of "microbiome-based drug or medicine" using useful bacteria are expected to have therapeutic effects on various diseases. In this talk, I will introduce the possibility of Blautia as a candidate of microbiome-based drug, which we found in a cohort study of Japanese people, which is expected to be effective against obesity and diabetes. I will also outline the regulatory research to realize the microbiome-based drug.